OSA's Digital Library

Optics Express

Optics Express

  • Editor: C. Martijn de Sterke
  • Vol. 17, Iss. 15 — Jul. 20, 2009
  • pp: 12502–12509
« Show journal navigation

Real-time microscopic imaging of esophageal epithelial disease with autofluorescence under ultraviolet excitation

Bevin Lin, Shiro Urayama, Ramez M. G. Saroufeem, Dennis L. Matthews, and Stavros G. Demos  »View Author Affiliations


Optics Express, Vol. 17, Issue 15, pp. 12502-12509 (2009)
http://dx.doi.org/10.1364/OE.17.012502


View Full Text Article

Acrobat PDF (2064 KB)





Browse Journals / Lookup Meetings

Browse by Journal and Year


   


Lookup Conference Papers

Close Browse Journals / Lookup Meetings

Article Tools

Share
Citations

Abstract

Detection of esophageal disease in current clinical practice is limited to visualization of macroscopic epithelial morphology. In this work, we investigate high resolution autofluorescence imaging under ultra violet excitation to visualize microscopic epithelial changes related to disease progression using a bench top prototype microscope. The approach is based on the hypothesis that UV excitation light can only penetrate the superficial layer of cells resulting in autofluorescence images of the epithelial layer without using an additional image sectioning approach. The experiments were performed using ex vivo human esophagus biopsy specimens. The results indicate that cellular morphology information related to disease progression is attainable without tissue preparation.

© 2009 Optical Society of America

1. Introduction

Esophageal adenocarcinoma claims 90% of all diagnosed patients within five years [1

1. S. Ekman, M. Dreilich, J. Lennartsson, B. Wallner, D. Brattstrom, M. Sundbom, and M. Bergqvist, “Esophageal cancer: current and emerging therapy modalities,” Expert Rev. Anticanc. 8, 1433–1448 (2008). [CrossRef]

]. Incidences of the disease have been increasing faster than any other malignancies in the U.S.A. [2

2. K. F. Trivers, S. A. Sabatino, and S. L. Stewart, “Trends in esophageal cancer incidence by histology, United States, 1998–2003,” I. J.Cancer 123, 1422–1428 (2008).

]. Up to 44% of presenting patients with advanced disease have no symptoms until the disease have become invasive [3

3. J. J. G. H. M. Bergman and G. N. J. Tytgat, “New developments in the endoscopic surveillance of Barrett’s oesophagus,” Gut 54, I38–I42 (2005). [CrossRef] [PubMed]

]. At this advanced stage, esophageal resection or chemoradiation becomes the only means of curative therapy with associated morbidity and mortality [4

4. B. Agarwal, S. G. Swisher, J. Ajani, K. Kelly, Komaki R. R., E. Abu-Hamda, A. M. Correa, and J. A. Roth, “Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett’s esophagus and symptomatic gastroesophageal reflux,” Ann. Thorac. Surg. 79, 1716–1723 (2005). [CrossRef] [PubMed]

,5

5. F. P. Peters, M. A. Kara, W. D. Rosmolen, F. J. W. ten Kate, K. K. Krishnadath, J. J. B. van Lanschot, P. Fockens, and J. J. G. H. M. Bergman, “Stepwise radical endoscopic resection is effective for complete removal of Barrett’s esophagus with early neoplasia: A prospective study,” Am. J. Gastroenterol. 101, 1449–1457 (2006). [CrossRef] [PubMed]

] in comparison to less invasive local endoscopic therapies being developed for earlier stage superficial lesions within the mucosa, including mucosal resection and ablative techniques [6

6. M. I. Canto, K. B. Dunbar, P. Okolo, S. B. Jagannath, and S. V. Kantsevoy, “Low flow CO2-cryotherapy for high risk Barrett’s esophagus (BE) patients with high grade dysplasia and early adenocarcinoma: A pilot trial of feasibility and safety,” Gastrointest. Endosc. 67, Ab179–Ab180 (2008). [CrossRef]

10

10. S. Wani, S. R. Puli, N. J. Shaheen, B. Westhoff, S. Slehria, A. Bansal, A. Rastogi, H. Sayana, and P. Sharma, “Esophageal Adenocarcinoma in Barrett’s Esophagus After Endoscopic Ablative Therapy: A Meta-Analysis and Systematic Review,” Am. J. Gastroenterol. 104, 502–513 (2009). [CrossRef] [PubMed]

]. In the currently identified high-risk group such as patients with Barrett’s esophagus, surveillance recommendations have been developed [11

11. S. J. Spechler and H. Barr, “Review article: screening and surveillance of Barrett’s esophagus: what is a cost-effective framework?,” Aliment Pharmacol. Ther. 19, 49–53 (2004). [CrossRef] [PubMed]

]. However, limited visualization of epithelial microstructures during endoscopy restricts the ability to detect early changes of disease progression. Our ultimate goal is to develop a device capable of highly accurate imaging of esophageal disease progression from Barrett’s esophagus to adenocarcinoma, in a heterogeneous cellular population lining the esophageal mucosa.

An array of optical tissue characterization techniques including fluorescence, light scattering, Raman, and Fourier-transform infrared spectroscopy have been explored as diagnostic tools for early detection of esophageal lesions [12

12. I. Georgakoudi, B. C. Jacobson, J. Van Dam, V. Backman, M. B. Wallace, M. G. Muller, Q. Zhang, K. Badizadegan, D. Sun, G. A. Thomas, L. T. Perelman, and M. S. Feld, “Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett’s esophagus,” Gastroenterology 120, 1620–1629 (2001). [CrossRef] [PubMed]

16

16. C. A. Lieber, S. Urayama, N. Rahim, R. Tu, R. Saroufeem, B. Reubner, and S. G. Demos, “Multimodal near infrared spectral imaging as an exploratory tool for dysplastic esophageal lesion identification,” Opt. Express 14, 2211–2219 (2006). [CrossRef] [PubMed]

]. Optical coherence tomography (OCT) has shown ability to provide images of structural components [17

17. A. Das, M. V. Sivak, A. Chak, R. C. K. Wong, V. Westphal, A. M. Rollins, J. Willis, G. Isenberg, and J. A. Izatt, “High-resolution endoscopic imaging of the GI tract: a comparative study of optical coherence tomography versus high-frequency catheter probe EUS,” Gastrointest. Endosc. 54, 219–224 (2001). [CrossRef] [PubMed]

,18

18. J. A. Evans, J. M. Poneros, B. E. Bouma, J. Bressner, E. F. Halpern, M. Shishkov, G. Y. Lauwers, M. Mino-Kenudson, N. S. Nishioka, and G. J. Tearney, “Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett’s esophagus,” Clin. Gastroenterol. H. 4, 38–43 (2006). [CrossRef]

]. A number of recently developed endomicroscopy systems have also shown promise of increasing sensitivity for disease detection. These include wide-field and confocal endomicroscopy that use visible or white light in conjunction with narrow band imaging or exogenous agents to maximize contrast in the esophagus [19

19. G. K. Anagnostopoulos, K. Yao, P. Kaye, C. J. Hawkey, and K. Ragunath, “Novel endoscopic observation in Barrett’s oesophagus using high resolution magnification endoscopy and narrow band imaging ,” Aliment Pharmacol. Ther. 26, 501–507 (2007). [PubMed]

23

23. M. Nakao, S. Yoshida, S. Tanaka, Y. Takemura, S. Oka, M. Yoshihara, and K. Chayama, “Optical biopsy of early gastroesophageal cancer by catheter-based reflectance-type laser-scanning confocal microscopy,” J. Biomed. Opt. 13, 054043-1–054043-5, (2008). [CrossRef]

]. While these studies have provided promising results, further optimization of this type of technology may expedite its acceptance by the medical community and the health care system.

2. Materials and Methods

This study was conducted in accordance with an institutional review board (IRB) approved protocol at the University of California, Davis Medical Center. The preliminary results reported in this work represent the findings from an initial population of 30 patients with a history of Barrett’s esophagus.

Fig. 1. Schematic depicting the autofluorescence microscopy system. Inset illustrates specimen placement.

Figure 1 illustrates the experimental arrangement for the imaging of the esophagus tissue specimens used in this study. In brief, a compact diode-pumped solid state laser operating at 266 nm (Intelite, Inc., Minden, NV) was the main light source used to excite the samples and generate the AF images, which were recorded using a liquid nitrogen cooled charge coupled device (Princeton Instruments, Inc., Trenton NJ). Additional compact lasers operating at 355 nm, 405 nm, and a white light source shown in Fig. 1 were used in the preliminary phase of the study that was focused on determining the optimal excitation wavelength.

Figure 2 demonstrates the images of the same specimen under a) 266 nm, b) 355 nm, and c) 408 nm laser excitation along with an image acquired using the same set-up under (d) white light illumination. The contrast in these images was linearly adjusted to qualitatively optimize visualization of the tissue microstructure. The features observed in the white light illumination image (Fig. 2d) were due to artifacts arising from dust on the optical elements. These artifacts are also visible in the AF images under 355 nm and 408 nm excitation, but not under 266 nm excitation. On the other hand, it can be readily appreciated that the images acquired under excitation at 266 nm provided the highest image contrast. For this reason, we focused our attention in the analysis of the experimental results obtained under 266 nm excitation.

The images under 266 nm excitation were acquired using a 5 second exposure time with an approximate dose of 30 mJ/cm2. This yielded images with a digitized intensity of about 5000 counts per pixel. It must be noted that high quality images under these excitation conditions were possible with exposure times shorter than one second (or images with digitized intensity of about 500 counts per pixel or higher), but we chose this exposure time in order to optimize image quality. The optical elements used in the microscope were not transmitting UV light, thus the image acquired were based on emission in the visible range. To better quantify the spectral range used for imaging, a 400 nm long pass filter was positioned in front of the CCD. Consequently, the experimental method and results described in this work can be translated for potential future adaptation into commercial endomicroscope systems that are currently capable of imaging only in the visible spectral range.

3. Results

Typical AF images under 266 nm excitation illustrating the observed epithelial morphology associated with various stages of esophageal disease progression are shown below. The images shown were selected as representative of distinct classifications based on the opinion of the expert pathologist. Specifically, Fig. 3(a) shows an image of normal squamous mucosa while Fig. 3(b) that of normal glandular mucosa. AF images of Barrett’s esophagus segments are shown in Fig. 4(a) and Fig. 4(b). High-grade dysplasia is shown in Fig. 5(a), while Fig. 5(b) represents an adenocarcinoma specimen. These images demonstrated visualization of microstructure morphology that could not be attained during a routine endoscopy. Comparing these AF images with histopathology is a crucial step in establishing the foundation necessary for assessing tissue status in vivo. Specifically, we wanted to explore the possibility that information needed for the evaluation of cell organization and morphology can be attained from images such as shown in Figs. 3, 4, and 5.

Fig. 2. Image of a 300 µm×270 µm area of a human esophagus columnar epithelium specimen under a) 266 nm, b) 355 nm, c) 408 nm excitation, and d) white light illumination.

The image of normal stratified squamous mucosa of the esophagus in Fig. 3(a), showed characteristic tile-like appearance of squamous cells with well demarcated edges at the periphery, probably corresponding to intercellular junctions. The image shown in Fig. 3(b) was from a biopsy specimen collected near the squamocolumnar junction and indicated regular rounded cells with a “honey-comb” appearance of normal glandular mucosa, characteristic of simple columnar epithelium.

Figure 4(a) demonstrates an AF image of a Barrett’s esophagus specimen from non-nodular distal esophageal mucosa. This image exhibits a similar appearance to that of normal glandular epithelium. However, the darker features indicated by arrows may represent goblet cells. This suggested that Barrett’s esophagus could potentially be identified among the glandular distal esophageal epithelium, a capability not yet available to the endoscopist. Another example of diseased tissue that appeared normal during endoscopic examination is shown in Fig. 4(b). This image was taken of a patient biopsy specimen whose pathology revealed dysplasia. The dysplasia was noted to be focal and high-grade rather than low-grade.

Fig. 3. Autofluorescence images under 266 nm excitation of a 434 µm×301 µm section of human esophagus of a) squamous mucosa, b) glandular mucosa.
Fig. 4. Autofluorescence image of human a) Barrett’s esophagus, b) dysplastic glandular epithelium under 266 nm excitation. Arrows designate what could be goblet cells

Figure 5(a) illustrates the image of a specimen taken from a patient with high-grade dysplasia and suspicion for adenocarcinoma, reflecting the variation of optical images in relation to the grade of dysplasia and its heterogeneity. Microstructure distortion and change of epithelial morphology was obvious. Early onset of these micro-changes is generally invisible during standard endoscopy and remains undetected until the diseased tissue has reached a symptomatic stage of adenocarcinoma, as illustrated in Fig. 5(b). This biopsy specimen was obtained from the central portion of a visible tumor approximately 5 cm in length. Figs. 5(a) and 5(b) shared similar deviations from normal glandular epithelial cellular structure. Both specimen images demonstrated a loss of the specific cellular patterns that characterized normal epithelium.

High-grade dysplasia was difficult to identify immediately in Fig. 5(a), in part due to the suspicion that this specimen also contained adenocarcinoma. Adenocarcinoma, shown in Fig. 5(b), had a three-dimensional villiform pattern, visibly different from the surface layer of normal glandular cells. Pathological evaluation relies on cross-sectional view of the biopsies to identify features such as nuclear and cellular disorganizations and basement polarity that indicate dysplastic and malignant activity. However, Figs. 3, 4, and 5 demonstrated that there were clear changes in the cellular contour and organization patterns from normal to adenocarcinoma epithelium that could be appreciated with AF microscopy.

Fig. 5. Autofluorescence images of human esophagus a) high-grade dysplasia, b) adenocarcinoma.

4. Discussion

The imaging approach discussed in this work enables real-time acquisition and display of images depicting the microstructure of the epithelial layer, which can potentially provide diagnostic information. All human esophagus specimens used in this study were unprocessed and unstained, and the images were acquired shortly after the biopsies were obtained in the operating room. Arguably, eliminating the need to prepare the tissue area to be imaged represents a major comparative advantage of this approach. This method, if implemented in vivo, could provide endoscopists with images of cellular morphology to assist in identifying early disease progression of the esophagus. These critical microscopic changes are invisible under currently used standard endoscopes.

AF emission spectra from various tissue types under UV excitation wavelengths shorter than about 300 nm have been previously investigated [25

25. B. Banerjee, B. Miedema, and H. R. Chandrasekhar, “Emission spectra of colonic tissue and endogenous fluorophores,” Am. J. Med. Sci. 316, 220–226 (1998). [CrossRef] [PubMed]

,26

26. A. P. Michalopoulou, J. T. Fitzgerald, C. Troppmann, and S. G. Demos, “Spectroscopic imaging for detection of ischemic injury in rat kidneys by use of changes in intrinsic optical properties,” Appl. Optics 44, 2024–2032 (2005). [CrossRef]

]. These results suggested that the emission profiles were similar to that of tryptophan, displaying a peak around 330 nm and a smooth tail extending beyond 400 nm. However, although tryptophan may be the dominant source of AF signal at the tissue level, the emission of some components giving rise to the AF microscopic images presented in this work may be due to various amounts of emission from other tissue fluorophores. We are currently working to address this issue in detail and we plan to report our findings at a later time.

Although the optical technique presented does not have sectioning capability, the results clearly demonstrate that the superficial photon propagation at 266 nm excitation provides imaging of cellular morphology of the epithelial layer. We postulate that the technology presented in our research matches or exceeds the performance of other emerging photonic techniques aimed at providing visualization of tissue microstructure in real-time. For example, Fig. 3(a) presents the superficial layer of squamous cells with visible nuclei that appear to be bright, although nuclei in the subsequent images appear to be dark. This discrepancy may be due to the nature of the stratified epithelia. As the basement layers gradually move toward the lumen of the esophagus, they lose their cuboidal shape for a more squamous surface. The nucleus flattens and undergoes pyknosis (densification) during later stages of maturation. As part of maturation, the nuclei are small and many cells have no nuclei. Imaging cells without nuclei, apoptotic cells, pyknotic nuclei, or the lamina propria surface may produce variable optical results. Nuclei are not clearly visible in the columnar epithelium of Fig. 3(b), probably due to small size and basal location along the basement membrane. Despite this, squamous and glandular mucosa characteristics were easily recognized in the optical images even by a non-expert.

While squamous and columnar epithelia are clearly outlined in Figs. 3(a) and 3(b), a greater challenge would be to identify glandular mucosa from specialized intestinal metaplasia, such as the example in Fig. 4(a). This image contains visible microstructures that are believed to be goblet cells, a defining characteristic of Barrett’s esophagus that is not visible without microscopic capabilities. Dysplastic tissue also cannot be ascertained during routine endoscopic surveillance. Microscopic changes associated with dysplasia were seen in Fig. 4(b). This biopsy specimen was collected from a patient who underwent esophagectomy that showed extensive high grade dysplasia without invasion. The nodular appearance of the AF image most likely corresponds to the polypoid dysplastic epithelium.

The challenge in standard pathology and likely with AF microscopy is to differentiate low grade from high grade dysplasia of the esophagus, particularly in view of the well recognized variation of inter-observer and intra-observer reproducibility. Difficulty of microstructure recognition is compounded by the heterogeneous nature of esophageal adenocarcinoma. Barrett’s esophagus and adenocarcinoma may be present with or without low or high grade dysplasia, increasing the variability of results obtained from the same patient. However, independent of this variability, an optical image using the method discussed in this work is always attainable and may be used to extract diagnostic information when the rules of interpretation to be developed are validated.

Dysplastic epithelium, seen in Figs. 4(b), 5(a), and 5(b), illustrated altered organizational and morphological characteristics of tissue at the microscopic level. These images may be considered as offering a projection of increasingly 3-dimensional cells on the 2-dimensional imaging plane, as opposed to the characteristically flattened 2-dimensional surface of squamous and columnar epithelia in Figs. 3(a), 3(b), and 4(a). The 3-dimensional progression and heterogeneity of tissue morphology associated with disease compounds the difficulty in focusing a single plane by adding an additional variable to the imaging process. Our data is based upon correlating the pathological findings with the AF images of the same specimen. Interpretation of the AF images in normal tissue has relatively higher accuracy and precision in view of the uniformity of cell type, compared to tissues with different cell types (squamocolumnar junction, goblet cells and various grades of dysplasia) which will need more extensive review and correlation of optical images with the pathology. Future work will focus on developing rules of interpretation to enable or assist the utilization of the diagnostic information embedded in the optical images in real-time by the endoscopist.

Obtaining diagnostic information in real-time without contrast agents, sample preparation, time intensive, or prohibitively expensive and complicated instrumentation may be necessary for acceptance of such technology by the medical community and the health care system. This AF method has been implemented for the examination of freshly excised tissue before pathology diagnosis. In this case, UV exposure will not be an issue since low intensity avoids compromise of the tissue sample. While this proof of principle work holds promise that in vivo microscopic AF imaging of tissue is possible via endoscopy, the use of laser excitation, particularly in the UV, will require a design that minimizes exposure and optimizes signal throughput. The AF images presented in this work were acquired under an approximate dose of 30 mJ/cm2 but images acquired with one tenth of that exposure were of reasonably high quality (see Materials and Methods section). In addition, the AF images were collected using a 400 nm long pass filter, thus rejecting most of the emission signal under 266 nm excitation. Moreover, the CCD detector was not optimized for highest sensitivity in this spectral region (400–500 nm). Therefore, we believe that a system designed with similar optical parameters but optimized for signal detection should easily meet the maximum permissible exposure (MPE) designated ANSI standard for exposure to UV wavelengths between 180 nm–302 nm of 3 mJ/cm2 [27

27. American National Standards Institute, ANSI Standard Z136.1 2000

]. Ultimately, in vivo AF microscopy may provide information for disease diagnosis that may help detect esophageal disease at an earlier stage. We postulate that the same technique may be suitable for application in other tissue systems. In the case of the current gold standard, stained tissue sections are imaged and interpreted using standard methods that have been developed to assist diagnosis such as the Vienna classification system [28

28. M. Stolte “The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages.” Virchows. Arch. 442.2 (2003). [PubMed]

]. The Vienna classification is a standard used with the exception of category 4.2 noninvasive carcinoma (carcinoma in situ), which is not used. Diagnosis of disease with AF microscopy might require the development of analogous rules.

Acknowledgements

We thank the gastroenterology medical team at the University of California, Davis Medical Center for their patience and assistance with this study, and Evan Applegate for his help. This work performed in part under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. This research is supported by funding from the Center for Biophotonics, an NSF Science and Technology Center, managed by the University of California, Davis, under Cooperative Agreement No. PHY 0120999.

References and links

1.

S. Ekman, M. Dreilich, J. Lennartsson, B. Wallner, D. Brattstrom, M. Sundbom, and M. Bergqvist, “Esophageal cancer: current and emerging therapy modalities,” Expert Rev. Anticanc. 8, 1433–1448 (2008). [CrossRef]

2.

K. F. Trivers, S. A. Sabatino, and S. L. Stewart, “Trends in esophageal cancer incidence by histology, United States, 1998–2003,” I. J.Cancer 123, 1422–1428 (2008).

3.

J. J. G. H. M. Bergman and G. N. J. Tytgat, “New developments in the endoscopic surveillance of Barrett’s oesophagus,” Gut 54, I38–I42 (2005). [CrossRef] [PubMed]

4.

B. Agarwal, S. G. Swisher, J. Ajani, K. Kelly, Komaki R. R., E. Abu-Hamda, A. M. Correa, and J. A. Roth, “Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett’s esophagus and symptomatic gastroesophageal reflux,” Ann. Thorac. Surg. 79, 1716–1723 (2005). [CrossRef] [PubMed]

5.

F. P. Peters, M. A. Kara, W. D. Rosmolen, F. J. W. ten Kate, K. K. Krishnadath, J. J. B. van Lanschot, P. Fockens, and J. J. G. H. M. Bergman, “Stepwise radical endoscopic resection is effective for complete removal of Barrett’s esophagus with early neoplasia: A prospective study,” Am. J. Gastroenterol. 101, 1449–1457 (2006). [CrossRef] [PubMed]

6.

M. I. Canto, K. B. Dunbar, P. Okolo, S. B. Jagannath, and S. V. Kantsevoy, “Low flow CO2-cryotherapy for high risk Barrett’s esophagus (BE) patients with high grade dysplasia and early adenocarcinoma: A pilot trial of feasibility and safety,” Gastrointest. Endosc. 67, Ab179–Ab180 (2008). [CrossRef]

7.

S. R. DeMeester, “New options for the therapy of Barrett’s high-grade dysplasia and intramucosal adenocarcinoma: Endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy,” Ann. Thorac. Surg. 85, S747–S750 (2008). [CrossRef] [PubMed]

8.

G. Y. Lauwers, D. G. Forcione, N. S. Nishioka, V. Deshpande, M. Y. Lisovsky, W. R. Brugge, and M. Mino-Kenudson, “Novel endoscopic therapeutic modalities for superficial neoplasms arising in Barrett’s esophagus: a primer for surgical pathologists,” Mod Pathol. 22, 489–498 (2009). [CrossRef] [PubMed]

9.

H. Mork, O. Al-Taie, F. Berlin, M. R. Kraus, and M. Scheurlen, “High recurrence rate of Barrett’s epithelium during long-term follow-up after argon plasma coagulation,” Scand. J. Gastroentero. 42, 23–27 (2007). [CrossRef]

10.

S. Wani, S. R. Puli, N. J. Shaheen, B. Westhoff, S. Slehria, A. Bansal, A. Rastogi, H. Sayana, and P. Sharma, “Esophageal Adenocarcinoma in Barrett’s Esophagus After Endoscopic Ablative Therapy: A Meta-Analysis and Systematic Review,” Am. J. Gastroenterol. 104, 502–513 (2009). [CrossRef] [PubMed]

11.

S. J. Spechler and H. Barr, “Review article: screening and surveillance of Barrett’s esophagus: what is a cost-effective framework?,” Aliment Pharmacol. Ther. 19, 49–53 (2004). [CrossRef] [PubMed]

12.

I. Georgakoudi, B. C. Jacobson, J. Van Dam, V. Backman, M. B. Wallace, M. G. Muller, Q. Zhang, K. Badizadegan, D. Sun, G. A. Thomas, L. T. Perelman, and M. S. Feld, “Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett’s esophagus,” Gastroenterology 120, 1620–1629 (2001). [CrossRef] [PubMed]

13.

L. B. Lovat, K. Johnson, G. D. Mackenzie, B. R. Clark, M. R. Novelli, S. Davies, M. O’Donovan, C. Selvasekar, S. M. Thorpe, D. Pickard, R. Fitzgerald, T. Fearn, I. Bigio, and S. G. Bown, “Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett’s esophagus,” Gut 55, 1078–1083 (2006). [CrossRef] [PubMed]

14.

C. Kendall, N. Stone, N. Shepherd, K. Geboes, B. Warren, R. Bennett, and H. Barr, “Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett’s esophagus,” J. Pathol. 200, 602–609 (2003). [CrossRef] [PubMed]

15.

Q. B. Li, X. J. Sun, Y. Z. Xu, L. M. Yang, Y. F. Zhang, S. F. Weng, J. S. Shi, and J. G. Wu, “Diagnosis of gastric inflammation and malignancy in endoscopic biopsies based on Fourier transform infrared spectroscopy,” Clin. Chem. 51, 346–350 (2005). [CrossRef] [PubMed]

16.

C. A. Lieber, S. Urayama, N. Rahim, R. Tu, R. Saroufeem, B. Reubner, and S. G. Demos, “Multimodal near infrared spectral imaging as an exploratory tool for dysplastic esophageal lesion identification,” Opt. Express 14, 2211–2219 (2006). [CrossRef] [PubMed]

17.

A. Das, M. V. Sivak, A. Chak, R. C. K. Wong, V. Westphal, A. M. Rollins, J. Willis, G. Isenberg, and J. A. Izatt, “High-resolution endoscopic imaging of the GI tract: a comparative study of optical coherence tomography versus high-frequency catheter probe EUS,” Gastrointest. Endosc. 54, 219–224 (2001). [CrossRef] [PubMed]

18.

J. A. Evans, J. M. Poneros, B. E. Bouma, J. Bressner, E. F. Halpern, M. Shishkov, G. Y. Lauwers, M. Mino-Kenudson, N. S. Nishioka, and G. J. Tearney, “Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett’s esophagus,” Clin. Gastroenterol. H. 4, 38–43 (2006). [CrossRef]

19.

G. K. Anagnostopoulos, K. Yao, P. Kaye, C. J. Hawkey, and K. Ragunath, “Novel endoscopic observation in Barrett’s oesophagus using high resolution magnification endoscopy and narrow band imaging ,” Aliment Pharmacol. Ther. 26, 501–507 (2007). [PubMed]

20.

W. L. Curvers, P. Fockens, J. J. Bergrnan, R. Singh, K. Ragunath, L. W. K. Song, K. K. Wang, H. C. Wolfsen, and M. B. Wallace, “Endoscopic trimodal imaging improves the detection of high-grade dysplasia (HGD) and early cancer (EC) in Barrett’s esophagus: An international multicenter study,” Gastroenterology 132, 2586–2586 (2007). [CrossRef]

21.

C. Gheorghe, R. Iacob, G. Becheanu, and M. Dumbrava, “Confocal endomicroscopy for in vivo microscopic analysis of upper gastrointestinal tract premalignant and malignant lesions,” J. Gastrointest. Liver 17, 95–100 (2008).

22.

M. A. Kara, R. S. DaCosta, C. J. Streutker, N. E. Marcon, J. J. G. H. M. Bergman, and B. C. Wilson, “Characterization of tissue autofluorescence in Barrett’s esophagus by confocal fluorescence microscopy,” Dis. Esophagus 20, 141–150 (2007). [CrossRef] [PubMed]

23.

M. Nakao, S. Yoshida, S. Tanaka, Y. Takemura, S. Oka, M. Yoshihara, and K. Chayama, “Optical biopsy of early gastroesophageal cancer by catheter-based reflectance-type laser-scanning confocal microscopy,” J. Biomed. Opt. 13, 054043-1–054043-5, (2008). [CrossRef]

24.

S. G Demos, C. A. Lieber, B. Lin, and R. Ramsamooj, “Imaging of tissue microstructures using a multimodal microscope design,” IEEE J. Sel. Top. Quantum Electron. 11, 752–758 (2005). [CrossRef]

25.

B. Banerjee, B. Miedema, and H. R. Chandrasekhar, “Emission spectra of colonic tissue and endogenous fluorophores,” Am. J. Med. Sci. 316, 220–226 (1998). [CrossRef] [PubMed]

26.

A. P. Michalopoulou, J. T. Fitzgerald, C. Troppmann, and S. G. Demos, “Spectroscopic imaging for detection of ischemic injury in rat kidneys by use of changes in intrinsic optical properties,” Appl. Optics 44, 2024–2032 (2005). [CrossRef]

27.

American National Standards Institute, ANSI Standard Z136.1 2000

28.

M. Stolte “The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages.” Virchows. Arch. 442.2 (2003). [PubMed]

OCIS Codes
(170.1610) Medical optics and biotechnology : Clinical applications
(170.2520) Medical optics and biotechnology : Fluorescence microscopy
(170.2680) Medical optics and biotechnology : Gastrointestinal
(170.4730) Medical optics and biotechnology : Optical pathology
(260.7190) Physical optics : Ultraviolet
(170.6935) Medical optics and biotechnology : Tissue characterization

ToC Category:
Medical Optics and Biotechnology

History
Original Manuscript: April 29, 2009
Revised Manuscript: July 2, 2009
Manuscript Accepted: July 5, 2009
Published: July 8, 2009

Virtual Issues
Vol. 4, Iss. 9 Virtual Journal for Biomedical Optics

Citation
Bevin Lin, Shiro Urayama, Ramez M. G. Saroufeem, Dennis L. Matthews, and Stavros G. Demos, "Real-time microscopic imaging of esophageal epithelial disease with autofluorescence under ultraviolet excitation," Opt. Express 17, 12502-12509 (2009)
http://www.opticsinfobase.org/oe/abstract.cfm?URI=oe-17-15-12502


Sort:  Author  |  Year  |  Journal  |  Reset  

References

  1. S. Ekman, M. Dreilich, J. Lennartsson, B. Wallner, D. Brattstrom, M. Sundbom, and M. Bergqvist, "Esophageal cancer: current and emerging therapy modalities," Expert Rev. Anticanc. 8, 1433-1448 (2008). [CrossRef]
  2. K. F. Trivers, S. A. Sabatino, and S. L. Stewart, "Trends in esophageal cancer incidence by histology, United States, 1998-2003," I. J.Cancer 123, 1422-1428 (2008).
  3. J. J. G. H. M. Bergman, and G. N. J. Tytgat, "New developments in the endoscopic surveillance of Barrett's oesophagus," Gut 54, I38-I42 (2005). [CrossRef] [PubMed]
  4. B. Agarwal, S. G. Swisher, J. Ajani, K. Kelly, R. R. Komaki, E. Abu-Hamda, A. M. Correa, and J. A. Roth, "Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux," Ann. Thorac. Surg. 79, 1716-1723 (2005). [CrossRef] [PubMed]
  5. F. P. Peters, M. A. Kara, W. D. Rosmolen, F. J. W. ten Kate, K. K. Krishnadath, J. J. B. van Lanschot, P. Fockens, and J. J. G. H. M. Bergman, "Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: A prospective study," Am. J. Gastroenterol. 101, 1449-1457 (2006). [CrossRef] [PubMed]
  6. M. I. Canto, K. B. Dunbar, P. Okolo, S. B. Jagannath, and S. V. Kantsevoy, "Low flow CO2-cryotherapy for high risk Barrett's esophagus (BE) patients with high grade dysplasia and early adenocarcinoma: A pilot trial of feasibility and safety," Gastrointest. Endosc. 67, Ab179-Ab180 (2008). [CrossRef]
  7. S. R. DeMeester, "New options for the therapy of Barrett's high-grade dysplasia and intramucosal adenocarcinoma: Endoscopic mucosal resection and ablation versus vagal-sparing esophagectomy," Ann. Thorac. Surg. 85, S747-S750 (2008). [CrossRef] [PubMed]
  8. G. Y. Lauwers, D. G. Forcione, N. S. Nishioka, V. Deshpande, M. Y. Lisovsky, W. R. Brugge, and M. Mino-Kenudson, "Novel endoscopic therapeutic modalities for superficial neoplasms arising in Barrett's esophagus: a primer for surgical pathologists," Mod Pathol. 22, 489-498 (2009). [CrossRef] [PubMed]
  9. H. Mork, O. Al-Taie, F. Berlin, M. R. Kraus, and M. Scheurlen, "High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation," Scand. J. Gastroentero. 42, 23-27 (2007). [CrossRef]
  10. S. Wani, S. R. Puli, N. J. Shaheen, B. Westhoff, S. Slehria, A. Bansal, A. Rastogi, H. Sayana, and P. Sharma, "Esophageal Adenocarcinoma in Barrett's Esophagus After Endoscopic Ablative Therapy: A Meta-Analysis and Systematic Review," Am. J. Gastroenterol. 104, 502-513 (2009). [CrossRef] [PubMed]
  11. S. J. Spechler and H. Barr, "Review article: screening and surveillance of Barrett's esophagus: what is a cost-effective framework?," Aliment Pharmacol. Ther. 19, 49-53 (2004). [CrossRef] [PubMed]
  12. I. Georgakoudi, B. C. Jacobson, J. Van Dam, V. Backman, M. B. Wallace, M. G. Muller, Q. Zhang, K. Badizadegan, D. Sun, G. A. Thomas, L. T. Perelman, and M. S. Feld, "Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus," Gastroenterology 120, 1620-1629 (2001). [CrossRef] [PubMed]
  13. L. B. Lovat, K. Johnson, G. D. Mackenzie, B. R. Clark, M. R. Novelli, S. Davies, M. O'Donovan, C. Selvasekar, S. M. Thorpe, D. Pickard, R. Fitzgerald, T. Fearn, I. Bigio, and S. G. Bown, "Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett's esophagus," Gut 55, 1078-1083 (2006). [CrossRef] [PubMed]
  14. C. Kendall, N. Stone, N. Shepherd, K. Geboes, B. Warren, R. Bennett, and H. Barr, "Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett's esophagus," J. Pathol. 200, 602-609 (2003). [CrossRef] [PubMed]
  15. Q. B. Li, X. J. Sun, Y. Z. Xu, L. M. Yang, Y. F. Zhang, S. F. Weng, J. S. Shi, and J. G. Wu, "Diagnosis of gastric inflammation and malignancy in endoscopic biopsies based on Fourier transform infrared spectroscopy," Clin. Chem. 51, 346-350 (2005). [CrossRef] [PubMed]
  16. C. A. Lieber, S. Urayama, N. Rahim, R. Tu, R. Saroufeem, B. Reubner, and S. G. Demos, "Multimodal near infrared spectral imaging as an exploratory tool for dysplastic esophageal lesion identification," Opt. Express 14, 2211-2219 (2006). [CrossRef] [PubMed]
  17. A. Das, M. V. Sivak, A. Chak, R. C. K. Wong, V. Westphal, A. M. Rollins, J. Willis, G. Isenberg, and J. A. Izatt, "High-resolution endoscopic imaging of the GI tract: a comparative study of optical coherence tomography versus high-frequency catheter probe EUS," Gastrointest. Endosc. 54, 219-224 (2001). [CrossRef] [PubMed]
  18. J. A. Evans, J. M. Poneros, B. E. Bouma, J. Bressner, E. F. Halpern, M. Shishkov, G. Y. Lauwers, M. Mino-Kenudson, N. S. Nishioka, and G. J. Tearney, "Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus," Clin. Gastroenterol. H. 4, 38-43 (2006). [CrossRef]
  19. G. K. Anagnostopoulos, K. Yao, P. Kaye, C. J. Hawkey, and K. Ragunath, "Novel endoscopic observation in Barrett's oesophagus using high resolution magnification endoscopy and narrow band imaging," Aliment Pharmacol. Ther. 26, 501-507 (2007). [PubMed]
  20. W. L. Curvers, P. Fockens, J. J. Bergrnan, R. Singh, K. Ragunath, L. W. K. Song, K. K. Wang, H. C. Wolfsen, and M. B. Wallace, "Endoscopic trimodal imaging improves the detection of high-grade dysplasia (HGD) and early cancer (EC) in Barrett's esophagus: An international multicenter study," Gastroenterology 132, 2586 (2007). [CrossRef]
  21. C. Gheorghe, R. Iacob, G. Becheanu, and M. Dumbrava, "Confocal endomicroscopy for in vivo microscopic analysis of upper gastrointestinal tract premalignant and malignant lesions," J. Gastrointest. Liver 17, 95-100 (2008).
  22. M. A. Kara, R. S. DaCosta, C. J. Streutker, N. E. Marcon, J. J. G. H. M. Bergman, and B. C. Wilson, "Characterization of tissue autofluorescence in Barrett's esophagus by confocal fluorescence microscopy," Dis. Esophagus 20, 141-150 (2007). [CrossRef] [PubMed]
  23. M. Nakao, S. Yoshida, S. Tanaka, Y. Takemura, S. Oka, M. Yoshihara, and K. Chayama, "Optical biopsy of early gastroesophageal cancer by catheter-based reflectance-type laser-scanning confocal microscopy," J. Biomed. Opt.  13, 054043-1 - 054043-5 (2008). [CrossRef]
  24. S. G. Demos, C. A. Lieber, B. Lin, and R. Ramsamooj, "Imaging of tissue microstructures using a multimodal microscope design," IEEE J. Sel. Top. Quantum Electron. 11, 752-758 (2005). [CrossRef]
  25. B. Banerjee, B. Miedema, and H. R. Chandrasekhar, "Emission spectra of colonic tissue and endogenous fluorophores," Am. J. Med. Sci. 316, 220-226 (1998). [CrossRef] [PubMed]
  26. A. P. Michalopoulou, J. T. Fitzgerald, C. Troppmann, and S. G. Demos, "Spectroscopic imaging for detection of ischemic injury in rat kidneys by use of changes in intrinsic optical properties," Appl. Opt. 44, 2024-2032 (2005). [CrossRef]
  27. American National Standards Institute, ANSI Standard Z136.1 2000
  28. M. Stolte, "The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages." Virchows. Arch. 442, 99-106 (2003). [PubMed]

Cited By

Alert me when this paper is cited

OSA is able to provide readers links to articles that cite this paper by participating in CrossRef's Cited-By Linking service. CrossRef includes content from more than 3000 publishers and societies. In addition to listing OSA journal articles that cite this paper, citing articles from other participating publishers will also be listed.


« Previous Article  |  Next Article »

OSA is a member of CrossRef.

CrossCheck Deposited